Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia. 1974

R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
February 1977, Annals of internal medicine,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
June 1983, Tumori,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
November 2008, [Rinsho ketsueki] The Japanese journal of clinical hematology,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
February 1989, Transplantation proceedings,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
January 1993, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
February 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
January 1996, Acta oncologica (Stockholm, Sweden),
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
March 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
April 1980, The American journal of surgical pathology,
R G Graw, and H P Lohrmann, and M I Bull, and J Decter, and G P Herzig, and J M Bull, and B G Leventhal, and R A Yankee, and R H Herzig, and G R Krueger, and W A Bleyer, and M L Buja, and M H McGinniss, and H J Alter, and J Whang-Peng, and H R Gralnick, and C H Kirkpatrick, and E S Henderson
February 1993, Transplantation proceedings,
Copied contents to your clipboard!